Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00030225 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure
A Phase 2 study, sponsored by Vital Therapies.
- Completed
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT00030225: Completed Phase 2 study, sponsored by Vital Therapies.
NCT00030225 is a Phase 2 study that has completed, run by Vital Therapies. The registered enrollment target is 19 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00030225, a Phase 2 study, has completed, sponsored by Vital Therapies.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if treatment with the ELAD Bioartificial Liver Assist Device is beneficial to patients in Acute Liver Failure either as a bridge to liver transplant or bridge to native liver recovery.
Primary Outcome
30-day survival
Interventions
- BIOLOGICAL ELAD
- OTHER Standard of care (Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2002-01 |
| Est. Completion | 2003-02 |
| Phase | Phase 2 |
What the finished NCT00030225 record still lists
NCT00030225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which ELAD is the first listed.
NCT00030225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00030225 about?
NCT00030225 is a clinical study titled "Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure". The purpose of this study is to determine if treatment with the ELAD Bioartificial Liver Assist Device is beneficial to patients in Acute Liver Failure either as a bridge to liver transplant or bridge to native liver recovery.
What is the current status of trial NCT00030225?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2002-01. Estimated completion is 2003-02.
What interventions are being tested in trial NCT00030225?
The interventions under investigation include: ELAD (BIOLOGICAL), Standard of care (Control) (OTHER).
Who is sponsoring clinical trial NCT00030225?
This trial is sponsored by Vital Therapies, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00030225's enrollment target sits among peer trials
19 1894th of 2000 higher than 103 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia